Tag results

Trials tagged with: "amgen"

Amgen Romiplostim ITP

A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receving Romiplostim.

 
The primary objective is to describe the number of months with a subject platelet response over a 12 month treatment period.
 

The secondary objectives are:

  1. To describe the incidence of ITP remission.
  2. To describe the incidence of splenectomy. 
  3. To describe the incidence of adverse events.